merlin.computer

Krishna Yeshwant

Managing Partner at GV

Krishna Yeshwant is a Managing Partner at GV and an attending internist at Brigham and Women's Hospital in Boston. He joined Google in 2008, was part of the team that helped found GV, and led its early life sciences investing, including Flatiron Health and Foundation Medicine. He started GV's incubation program, which helped start Verve Therapeutics and ROME Therapeutics.

Now
Managing Partner, GV1
Joined Google
June 2008, New Business Development2
Studied
MD, Harvard Medical School; MBA, Harvard Business School2
Based in
Boston, Massachusetts, United States2

Experience

GV2009 – now
  1. Managing Partnernow

    Part of the team that helped found GV and led its early life sciences investing. He founded GV's incubation program and led early investments in Flatiron Health, Foundation Medicine, Relay Therapeutics, Beam Therapeutics, insitro, One Medical and Aledade.1

  2. Partner2From Jun 2009
Brigham and Women's Hospital2009 – now
  1. Attending internist1now
  2. Attending physician, Partners HealthCare2Jun 2009 – now
  3. ResidentAfter medical school

    Completed his residency at Brigham and Women's Hospital and practiced there for several years.4

Google2008 – 2009
  1. New Business Development2Jun 2008 – Jun 2009
insitronow
  1. Board Observer3now
Parabilis Medicinesnow
  1. Board member4now
Foundation MedicineBy 2015
  1. Independent directorBy 2015

    Stayed on the board as a continuing director when Roche became the majority shareholder.7

Image-guided surgery software2002
  1. Software developer2002

    Worked with surgeons at Massachusetts General Hospital and Brigham and Women's Hospital on software that uses imaging systems to guide surgery.1

Two early tech companiesEarly career
  1. Co-founderEarly career

    Co-founded an electronic data interchange company, later bought by Hewlett-Packard, and a network security company, later bought by Symantec.1

Education

Harvard Business School2007 – 2009

MBA2

Harvard Medical School2004 – 2009

Doctor of Medicine (MD)2

Stanford UniversityYear not published

B.S., Computer science3

Illinois Mathematics and Science Academy (IMSA)Year not published

2

Milestones

  1. Builds image-guided surgery software with surgeons at Massachusetts General and Brigham and Women's1
  2. Joins Google's New Business Development team2
  3. Starts as a partner at GV; finishes his MD and MBA at Harvard the same year2
  4. Stays on Foundation Medicine's board as Roche becomes its majority shareholder7
  5. Roche agrees to buy Flatiron Health, the oncology software and data company, for $1.9 billion8
  6. GV invests in Verve Therapeutics' Series A, with him and Anthony Philippakis as its GV investors6
  7. Roche agrees to buy the rest of Foundation Medicine at $137 a share, a $2.4 billion deal9
  8. Guest on GV's Theory and Practice podcast as a GV managing partner5
  9. Eli Lilly agrees to buy Verve Therapeutics for about $1.0 billion, or up to $1.3 billion if a later trial milestone is met10

Skills

  • Clinical research

you scrolled all the way down here

your next free moment starts in three minutes

getting started takes three minutes. sign in, and i'm on your to-dos, starting with who's waiting on you

you decide what comes after

Download for Mac Free forever. No credit card.